Although few prior studies showed the PD-L1 expression on tumour or immune cell in some GISTs,12,13 more extensive investigation using the diverse markers of TIME is needed for better understanding to make the strategies for future immunotherapy clinical trials.14 Furthermore, potential changes of TIME during the course of currently approved therapy are also important to estimate the optimal timing of the application of immunotherapy. Here, CD274 is linked to neoplasm.